GC32874
NMS-859
Also known as 2-chloro-N-[3-[(1,1-dioxo-1,2-benzothiazol-3-yl)amino]phenyl]acetamide
NMS-859 is a potent, covalent VCP (p97) inhibitor, with IC50s of 0·37 and 0·36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively
ChemicalCAS1449236-96-7MW349.79FormulaC15H12ClN3O3S
- CAS number
- 1449236-96-7
- Molecular weight
- 349.79
- Formula
- C15H12ClN3O3S
- Solubility
- DMSO ： ≥ 42 mg/mL (120·07 mM)
- InChIKey
- JWMFLBAPPIWNGG-UHFFFAOYSA-N
- Catalogue number
- GC32874
- Brand
- GLPBIO
Computed properties PubChem CID 71607189 · XLogP 1.8 · TPSA 96 Ų · H-bond donors 2
- XLogP
- 1.8
- TPSA
- 96 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 23
SMILES C1=CC=C2C(=C1)C(=NS2(=O)=O)NC3=CC(=CC=C3)NC(=O)CCl
Computed descriptors from PubChem (CID 71607189), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il